Table 2 Characteristics of DOACs patients and controls.
From: Management of ongoing direct anticoagulant treatment in patients with hip fracture
DOA (74) | Controls (206) | p | |
|---|---|---|---|
Mean age | 84 ± 5.4 | 84.1 ± 8.5 | ns |
Gender M/F | 24/50 (68%) | 49/157 (76.2%) | ns |
Type of fracture | |||
Neck fracture | 36 | 107 | ns |
Per trochanteric | 36 | 93 | ns |
Subtrochanteric | 2 | 6 | ns |
BADL | |||
≤ 4 | 21 (28%) | 50 (25%) | ns |
Previous mobility | |||
> 50 m | 20 | 65 | ns |
< 50 m | 29 | 74 | ns |
Home confined | 25 | 67 | ns |
ASA score | |||
3 | 69 | 195 | ns |
4 | 5 | 11 | |
Comorbidities | |||
Ischemic heart disease | 12 (16%) | 31 (15%) | ns |
Heart failure | 11 (14%) | 16 (8%) | |
Chronic obstructive pulmonary disease | 6 (8%) | 27 (13%) | ns |
Chronic renal failure | 5 (6%) | 14 (7%) | ns |
Cancer | 6 (8%) | 20 (5%) | ns |
Dementia | 19 (25%) | 44 (21%) | ns |
Hypertension | 44 (59%) | 141 (68%) | |
Diabetes mellitus | 17 (10%) | 37 (18%) | ns |
Parkinson disease | 4 (7.5%) | 19 (5%) | ns |
More than two comorbidities | 39 (52%) | 125 (60%) | 0.036 |
